Genentech Dumps Another $650M in New Haven Biotech Arvinas Post author:Sam Post published:November 14, 2017 Post category:BioPharma Arvinas expanded an ongoing licensing deal with Genentech. Source: BioSpace You Might Also Like Acadia Scraps a Phase II Alzheimer's Trial, Gets Breakthrough Tag for Dementia-Related Drug October 4, 2017 MindChild Medical Inc. Announces Publication Of "Evaluation Of The Fetal QT Interval Using Non-Invasive Fetal ECG Technology" With The MERIDIAN Fetal Monitoring System April 9, 2017 Cambridge's Exonics Therapeutics Scores $40M November 7, 2017
Acadia Scraps a Phase II Alzheimer's Trial, Gets Breakthrough Tag for Dementia-Related Drug October 4, 2017
MindChild Medical Inc. Announces Publication Of "Evaluation Of The Fetal QT Interval Using Non-Invasive Fetal ECG Technology" With The MERIDIAN Fetal Monitoring System April 9, 2017
